Next generation sequencing of breast implant‐associated anaplastic large cell lymphomas reveals a novel STAT3‐JAK2 fusion among other activating genetic alterations within the JAK‐STAT pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next generation sequencing of breast implant‐associated anaplastic large cell lymphomas reveals a novel
STAT3‐JAK2
fusion among other activating genetic alterations within the
JAK‐STAT
pathway
Authors
Keywords
-
Journal
Breast Journal
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-04
DOI
10.1111/tbj.14205
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
- (2020) Elaine S. Jaffe et al. JOURNAL OF CLINICAL ONCOLOGY
- 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- (2019) Mark W Clemens et al. Aesthetic Surgery Journal
- A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
- (2019) Kirill A. Lyapichev et al. MODERN PATHOLOGY
- Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract
- (2019) Guangzhen Hu et al. LEUKEMIA
- Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma
- (2018) Maria C. Ferrufino-Schmidt et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- RecurrentSTAT3-JAK2fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
- (2018) Ayush Sharma et al. BLOOD
- Genetic subtyping of breast implant-associated anaplastic large cell lymphoma
- (2018) Naoki Oishi et al. BLOOD
- Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma
- (2018) Audrey Letourneau et al. VIRCHOWS ARCHIV
- Breast implant-associated anaplastic large cell lymphoma: a review
- (2018) Andrés E. Quesada et al. MODERN PATHOLOGY
- Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
- (2017) Ioannis Panagopoulos et al. Oncotarget
- Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A
- (2016) Arianna Di Napoli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
- (2016) P. Blombery et al. HAEMATOLOGICA
- Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
- (2016) Mark W. Clemens et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis
- (2016) D Juskevicius et al. LEUKEMIA
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
- (2016) Ronglai Shen et al. NUCLEIC ACIDS RESEARCH
- Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma
- (2016) Stefan Ehrentraut et al. Oncotarget
- Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma
- (2016) P. Blombery et al. HAEMATOLOGICA
- Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes
- (2015) C. Laurent et al. ANNALS OF ONCOLOGY
- Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
- (2015) Ramona Crescenzo et al. CANCER CELL
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
- (2014) E. R. Parrilla Castellar et al. BLOOD
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
- (2013) Roberto N. Miranda et al. JOURNAL OF CLINICAL ONCOLOGY
- t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
- (2013) Stefan Ehrentraut et al. PLoS One
- Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas
- (2012) G. Vasmatzis et al. BLOOD
- Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
- (2010) A. L. Feldman et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now